A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Adherence Audiences

Download

With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes.

Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.